Laboratory for the Rehabilitation of Traumatic Injuries, Laboratory of Trauma, Center of Bone Metabolism and Repair, State Key Laboratory of Trauma, Burns and Combined Injury, Research Institute of Surgery, Laboratory for Prevention and Rehabilitation of Military Training Related Injuries, Daping Hospital, Army Medical University (Third Military Medical University), 400042, Chongqing, China.
Center for Joint Surgery, Southwest Hospital, Army Medical University (Third Military Medical University), 400038, Chongqing, China.
Cell Death Dis. 2019 Jul 8;10(7):522. doi: 10.1038/s41419-019-1739-2.
Synovitis, a common clinical symptom for osteoarthritis (OA) patients, is highly related to OA pathological progression and pain manifestation. The activated synovial macrophages have been demonstrated to play an important role in synovitis, but the mechanisms about macrophage activation are still not clear. In this study, we found that the exosome-like vesicles from osteoarthritic chondrocytes could be a new biological factor to stimulate inflammasome activation and increase mature IL-1β production in macrophages. The degraded cartilage explants produced more exosome-like vesicles than the nondegraded ones, while the exosome-like vesicles from chondrocytes could enter into joint synovium tissue and macrophages. Moreover, the exosome-like vesicles from osteoarthritic chondrocytes enhanced the production of mature IL-1β in macrophages. These vesicles could inhibit ATG4B expression via miR-449a-5p, leading to inhibition of autophagy in LPS-primed macrophages. The decreased autophagy promoted the production of mitoROS, which further enhanced the inflammasome activation and subsequent IL-1β processing. Ultimately, the increase of mature IL-1β may aggravate synovial inflammation and promote the progression of OA disease. Our study provides a new perspective to understand the activation of synovial macrophages and synovitis in OA patients, which may be beneficial for therapeutic intervention in synovitis-related OA patients.
滑膜炎是骨关节炎(OA)患者的常见临床症状,与 OA 的病理进展和疼痛表现密切相关。已证实活化的滑膜巨噬细胞在滑膜炎中发挥重要作用,但巨噬细胞活化的机制尚不清楚。在本研究中,我们发现骨关节炎软骨细胞来源的外泌体样小泡可作为一种新的生物因子,刺激炎症小体激活并增加巨噬细胞中成熟的 IL-1β产生。降解的软骨外植体产生的外泌体样小泡多于未降解的软骨外植体,而软骨细胞来源的外泌体样小泡可进入关节滑膜组织和巨噬细胞。此外,骨关节炎软骨细胞来源的外泌体样小泡增强了巨噬细胞中成熟 IL-1β的产生。这些小泡可通过 miR-449a-5p 抑制 ATG4B 的表达,从而抑制 LPS 预刺激的巨噬细胞中的自噬。自噬的减少促进了 mitoROS 的产生,进而增强了炎症小体的激活和随后的 IL-1β加工。最终,成熟的 IL-1β的增加可能会加重滑膜炎症,促进 OA 疾病的进展。我们的研究为理解 OA 患者滑膜巨噬细胞的激活和滑膜炎提供了新的视角,可能有益于对与滑膜炎相关的 OA 患者进行治疗干预。
Arthritis Res Ther. 2014-8-4
J Bone Joint Surg Am. 2016-7-6
Biorheology. 2002
Biomed Pharmacother. 2017-9-10
Cell Mol Immunol. 2025-7-14
J Orthop Surg Res. 2025-6-11
Mol Biomed. 2025-6-10
Front Immunol. 2025-3-17
Front Cell Dev Biol. 2025-3-5
Adv Biol (Weinh). 2024-12-31
Clin Chim Acta. 2018-11-9
Mol Ther Nucleic Acids. 2018-12-7
Biomed Pharmacother. 2018-6-19
JCI Insight. 2018-5-17